Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues ...

Stocks are set to close out April with major gains even as a war in the Middle East is ongoing, and fears around AI ...

We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Novavax, Inc. tops our list of the most ...

An mRNA vaccine for avian influenza, developed by pharma company Moderna, has begun Phase 3 human trials. Building on the ...

NEW YORK – Create Medicines has started clinically testing an in vivo CAR therapy that comprises a cancer-killing medley of T, NK, and myeloid cells.

Investing.com - German biotech company CureVac sued Moderna (NASDAQ:MRNA) in Delaware federal court on Friday, alleging that Moderna’s COVID-19 vaccine Spikevax infringed CureVac patents related to ...

The first participants in the UK and US have received Moderna’s mRNA-1018 vaccine in a phase 3 trial targeting the H5N1 bird flu strain. The study will test safety and immune response in about 4,000 ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Health and Human Services officials blocked the publication of a COVID-19 vaccine study slated for a Centers for Disease ...

Legend Biotech Corporation looks like a J&J acquisition target as Carvykti sales surge and Phase 2 data impress. Click for ...

After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the ...

A report from the CDC finds no secondary cases among passengers and crew who were near infected airline passengers.